Skip to main navigation Skip to search Skip to main content

Tempest Announces Positive Early Results from Global Randomized Phase 1b/2 Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma

Press/Media: Press / Media

PeriodApr 28 2023

Media coverage

1

Media coverage

  • TitleTempest Announces Positive Early Results from Global Randomized Phase 1b/2 Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma
    Media name/outletBioSpace
    Country/TerritoryUnited States
    Date4/28/23
    PersonsJulian Chen
View all 1
View less